mouse anti-human braf v600e monoclonal antibody ve1  (Spring Bioscience)

Journal: Annals of Surgical Oncology

Article Title: Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy

doi: 10.1245/s10434-020-08713-1

Figure Lengend Snippet: Lymphocyte biomarkers and distribution by BRAF mutation status

Article Snippet: For BRAF V600E IHC, Pleasanton, CA Spring Bioscience mouse anti-human BRAF V600E monoclonal antibody (Clone VE1) was used at a dilution of 1:200 run on a routine long program.

Techniques: Mutagenesis

Journal: Annals of Surgical Oncology

Article Title: Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy

doi: 10.1245/s10434-020-08713-1

Figure Lengend Snippet: Clinical response to DPCP correlated with OS by biomarker status

Article Snippet: For BRAF V600E IHC, Pleasanton, CA Spring Bioscience mouse anti-human BRAF V600E monoclonal antibody (Clone VE1) was used at a dilution of 1:200 run on a routine long program.

Techniques: Biomarker Assay

Journal: Annals of Surgical Oncology

Article Title: Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy

doi: 10.1245/s10434-020-08713-1

Figure Lengend Snippet: Lymphocyte biomarkers and distribution by BRAF mutation status

Article Snippet: For BRAF V600E IHC, Pleasanton, CA Spring Bioscience mouse anti-human BRAF V600E monoclonal antibody (Clone VE1) was used at a dilution of 1:200 run on a routine long program.

Techniques: Mutagenesis

Journal: Annals of Surgical Oncology

Article Title: Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy

doi: 10.1245/s10434-020-08713-1

Figure Lengend Snippet: Clinical response to DPCP correlated with OS by biomarker status

Article Snippet: For BRAF V600E IHC, Pleasanton, CA Spring Bioscience mouse anti-human BRAF V600E monoclonal antibody (Clone VE1) was used at a dilution of 1:200 run on a routine long program.

Techniques: Biomarker Discovery

Journal: Frontiers in Oncology

Article Title: BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas

doi: 10.3389/fonc.2018.00526

Figure Lengend Snippet: Clinical-pathological characteristics of patients and BRAF V600E immunostain intensity.

Article Snippet: As for immunohistochemistry, 3-micron paraffin embedded sections were dehydrated, pretreated with avidin block for 15' and biotin block for 15', then incubated with BSA for 30' and incubated with mouse anti-human BRAF V600E monoclonal antibody (clone VE1, Spring Bioscience) at room temperature for 60' (dilution 1:50, PT-link antigen retrival at high pH).

Techniques: Sequencing